These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 24135427
1. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial. Zaher H, Rasheed H, Esmat S, Hegazy RA, Gawdat HI, Hegazy RA, El-Komy M, Abdelhalim DM. Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427 [Abstract] [Full Text] [Related]
3. Topical propranolol for treatment of superficial infantile hemangiomas. Xu G, Lv R, Zhao Z, Huo R. J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113 [Abstract] [Full Text] [Related]
4. Propranolol for infantile hemangiomas. Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández-Martín A, Luna P, Gutiérrez M, Baño A, Tamariz A, Larralde M, Alvarez R, Pardo N, Baselga E. Pediatr Dermatol; 2011 Dec; 28(2):108-14. PubMed ID: 21385205 [Abstract] [Full Text] [Related]
5. A randomized, controlled trial of oral propranolol in infantile hemangioma. Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ. N Engl J Med; 2015 Feb 19; 372(8):735-46. PubMed ID: 25693013 [Abstract] [Full Text] [Related]
6. Topical timolol maleate for superficial infantile hemangiomas: an observational study. Xu DP, Cao RY, Tong S, Xue L, Sun NN, Wang XK. J Oral Maxillofac Surg; 2015 Jun 19; 73(6):1089-94. PubMed ID: 25843815 [Abstract] [Full Text] [Related]
7. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ovadia SA, Landy DC, Cohen ER, Yang EY, Thaller SR. Ann Plast Surg; 2015 Feb 19; 74(2):256-62. PubMed ID: 25590249 [Abstract] [Full Text] [Related]
8. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR. Int J Oral Maxillofac Surg; 2013 Jul 19; 42(7):863-7. PubMed ID: 23618833 [Abstract] [Full Text] [Related]
9. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Arch Dermatol; 2010 Jul 19; 146(7):775-8. PubMed ID: 20644039 [Abstract] [Full Text] [Related]
10. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients. Xu DP, Cao RY, Xue L, Sun NN, Tong S, Wang XK. J Oral Maxillofac Surg; 2015 Mar 19; 73(3):430-6. PubMed ID: 25544304 [Abstract] [Full Text] [Related]
11. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ. Br J Dermatol; 2013 Apr 19; 168(4):837-43. PubMed ID: 23278381 [Abstract] [Full Text] [Related]
12. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas. Babiak-Choroszczak L, Giżewska-Kacprzak K, Dawid G, Gawrych E, Bagłaj M. Adv Clin Exp Med; 2019 Mar 19; 28(3):375-384. PubMed ID: 30659785 [Abstract] [Full Text] [Related]
13. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T. Acta Paediatr; 2012 Oct 19; 101(10):e469-74. PubMed ID: 22804809 [Abstract] [Full Text] [Related]
14. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ, Hermans DJ, Dassel AC, van der Vleuten CJ, van Beynum IM. Int J Pediatr Otorhinolaryngol; 2013 Nov 19; 77(11):1791-800. PubMed ID: 24074695 [Abstract] [Full Text] [Related]
15. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Mashiah J, Kutz A, Rabia SH, Ilan EB, Goldberg I, Sprecher E, Harel A. Int J Dermatol; 2017 Feb 19; 56(2):148-153. PubMed ID: 28074521 [Abstract] [Full Text] [Related]
16. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated? Liu LS, Sokoloff D, Antaya RJ. Pediatr Dermatol; 2013 Feb 19; 30(5):554-60. PubMed ID: 23829941 [Abstract] [Full Text] [Related]
17. Late rebound of infantile hemangioma after cessation of oral propranolol. Shehata N, Powell J, Dubois J, Hatami A, Rousseau E, Ondrejchak S, McCuaig C. Pediatr Dermatol; 2013 Feb 19; 30(5):587-91. PubMed ID: 24016283 [Abstract] [Full Text] [Related]
18. [Treatment of superficial infantile hemangiomas with topical propranolol]. Niu JN, Xu GQ, Lü RR, Huo R. Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar 19; 29(2):100-3. PubMed ID: 23772486 [Abstract] [Full Text] [Related]
19. Failure of intralesional propranolol in infantile hemangiomas. Torres-Pradilla M, Baselga E. Pediatr Dermatol; 2014 Mar 19; 31(2):156-8. PubMed ID: 24000875 [Abstract] [Full Text] [Related]